Effect of neurological screening on early dementia detection in southern Italy.
Screening campaign
dementia
general practitioner
mild cognitive impairment
neurodegenerative disorders
neuroepidemiology
prevention
public health
Journal
The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Population screening can facilitate early diagnosis of dementia and improve disease management. This study examined the effects of a screening campaign for neurodegenerative disorders on the early diagnosis of dementia using 2-year follow-up data. A 5-day screening campaign was conducted that comprised neurological, neuropsychological and other specialist examinations. Identification of alterations during the neurological examination was followed-up by further diagnostic examinations to confirm the neurological impairment. Neurological alterations were observed in 39% of the screened subjects, who were mostly diagnosed with mild cognitive impairment and referred to a dementia and cognitive disorders centre. Suspicion of neurological impairment was a risk factor for inclusion in a specific neurological ambulatory follow-up and a condition for exemption from payment for medical examinations. Neurodegenerative screening initiatives should include subjects selected by general practitioners. It would be useful to create a network including primary care physicians and cognitive disorder centres. Telemedicine tools (e.g., teleconsulting) could also be used to facilitate early diagnosis.
Identifiants
pubmed: 33081552
doi: 10.1177/0300060520949763
pmc: PMC7588776
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
300060520949763Références
Comput Biol Med. 2018 Nov 1;102:234-241
pubmed: 30253869
J Gen Intern Med. 2007 Jun;22(6):811-7
pubmed: 17447100
Front Neurol. 2019 Jan 09;9:1169
pubmed: 30687223
Brain. 2010 Nov;133(11):3290-300
pubmed: 20823087
Diabetes Metab Syndr Obes. 2011;4:213-23
pubmed: 21760738
BMJ. 2014 Jul 24;349:g4791
pubmed: 25059715
Front Biosci (Landmark Ed). 2018 Jan 1;23:183-220
pubmed: 28930543
J Aging Res. 2018 Dec 2;2018:8352816
pubmed: 30631599
Lancet Neurol. 2017 Nov;16(11):877-897
pubmed: 28931491
BJPsych Bull. 2019 Jun;43(3):123-125
pubmed: 30606274
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Alzheimers Dement. 2013 Mar;9(2):151-9
pubmed: 23375564
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Inquiry. 2017 Jan 1;54:46958017713708
pubmed: 28617065
Front Mol Neurosci. 2019 Jan 07;11:483
pubmed: 30666187
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
BMC Med Inform Decis Mak. 2018 May 31;18(1):35
pubmed: 29855305
BMC Geriatr. 2015 Jun 16;15:66
pubmed: 26076729
Alzheimers Dement. 2019 Jul;15(7):927-939
pubmed: 31175025
Sci Rep. 2015 Apr 23;5:9904
pubmed: 25905450
Diagnostics (Basel). 2016 Jan 21;6(1):
pubmed: 26838803